Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke

Status:
Completed

Trial end date:
2018-08-03

Target enrollment:

Participant gender:

To assess the efficacy and to evaluate safety of HT047 in patients with acute ischemic stroke

Phase 2

Hocheol Kim